Krishna Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 34 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.44 M
- Revenue Growth 22.29%
- Profit Growth -25.99%
- Ebitda 1386.44%
- Net Worth 0.75%
- Total Assets 8.95%
About Krishna Biotech
Krishna Biotech Pvt Ltd (KBPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 June 1990 and has a history of 34 years and eight months. Its registered office is in Dist: Rajkot, Gujarat.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹6.44 M.
Jigneshkumar Bhalodi and Divyeshkumar Bhalodi serve as directors at the Company.
Company Details
- Location Dist: Rajkot, Gujarat
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999GJ1990PTC013892
-
Company No.
013892
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Jun 1990
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Krishna Biotech Pvt Ltd offer?
Krishna Biotech Pvt Ltd offers a wide range of products and services, including Insecticides and Pesticides, Termiticide, Insecticides, Biopesticides, Neem Pesticide, Fertilizers and Soil Additives, Fertilizer, Plant Growth Promoters, Flowering Stimulant.
Who are the key members and board of directors at Krishna Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jigneshkumar Bhalodi
|
Director | 30-Apr-2014 | Current |
|
Divyeshkumar Bhalodi
|
Director | 30-Apr-2014 | Current |
Financial Performance of Krishna Biotech.
Krishna Biotech Pvt Ltd, for the financial year ended 2017, experienced significant growth in revenue, with a 22.29% increase. The company also saw a substantial fall in profitability, with a 25.99% decrease in profit. The company's net worth moved up by a moderate rise of 0.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krishna Biotech?
In 2017, Krishna Biotech had a promoter holding of 79.00% and a public holding of 21.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.44 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.25 Cr
- Others : 0.20 Cr
- Gujarat State Financial Corporation : 0.12 Cr
- State Bank Of Saurashtra : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2017 | Others | ₹2.00 M | Open |
| 19 May 2003 | Bank Of Baroda | ₹1.00 M | Open |
| 16 May 2003 | Bank Of Baroda | ₹1.50 M | Open |
| 20 Mar 1992 | Gujarat State Financial Corporation | ₹1.24 M | Open |
| 15 Feb 1992 | State Bank Of Saurashtra | ₹0.70 M | Open |
How Many Employees Work at Krishna Biotech?
Unlock and access historical data on people associated with Krishna Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krishna Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krishna Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
